中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Viral Diseases
NASH
Cancer
Exploratory Indications
Products&Pipeline
Pipeline
Products
Clinical Trials
Partnership
Investors
Financials & Filing
Presentation Materials
News
Careers
Investors
Financials & Filing
Presentation Materials
2024
2023
2022
2021
2020
2019
2018
2024
2023
2022
2021
2020
2019
2018
Voluntary Announcement - Ascletis Announces Dosing of the First Patient in Phase III Clinical Trial of ASC40 (Denifanstat) for Treatment of Acne
2024-01-24
Next Day Disclosure Returns - Share Buyback
2024-01-22
Next Day Disclosure Returns - Share Buyback
2024-01-19
Next Day Disclosure Returns - Share Buyback
2024-01-18
Next Day Disclosure Returns - Share Buyback
2024-01-17
Next Day Disclosure Returns - Share Buyback
2024-01-16
Next Day Disclosure Returns - Share Buyback
2024-01-15
Next Day Disclosure Returns - Share Buyback
2024-01-12
Next Day Disclosure Returns - Share Buyback
2024-01-11
Next Day Disclosure Returns - Share Buyback
2024-01-10
«
5
6
7
8
»
浙公网安备 33010802003344号
浙ICP备11050387号-1
